1
00:00:01,280 --> 00:00:04,560
Speaker 1: This is taking stock with Kathleen Hayes and grim Box

2
00:00:04,720 --> 00:00:10,720
Speaker 1: on Bloomberg Radio, heart valves, pacemakers, catheters. Did they go

3
00:00:10,800 --> 00:00:15,360
Speaker 1: together with pharmaceuticals, nutritional items and contact lenses? Well they

4
00:00:15,400 --> 00:00:18,840
Speaker 1: do now because Abbott Laboratories has agreed to buy the

5
00:00:18,880 --> 00:00:23,520
Speaker 1: heart device makers St Jude Medical for five billion dollars.

6
00:00:23,840 --> 00:00:27,040
Speaker 1: Here to tell us more about the sector of the

7
00:00:27,080 --> 00:00:31,280
Speaker 1: world economy, Sasha domuni are Bloomberg Healthcare report of twenty

8
00:00:31,320 --> 00:00:33,159
Speaker 1: five billion dollars. You know that that used to be

9
00:00:33,200 --> 00:00:35,879
Speaker 1: considered a lot of money. Sasha tell us why is

10
00:00:35,920 --> 00:00:38,920
Speaker 1: this such a good and important deal for Abbott Labs.

11
00:00:39,320 --> 00:00:42,519
Speaker 1: It's a transformational deal for Abbott And if you think

12
00:00:42,560 --> 00:00:44,839
Speaker 1: about today. In fact, today has been very exciting on

13
00:00:44,880 --> 00:00:46,839
Speaker 1: the M and A front, and healthcare in particular. It's

14
00:00:46,880 --> 00:00:50,360
Speaker 1: been a forty billion dollar M and A day. So

15
00:00:50,600 --> 00:00:54,279
Speaker 1: Abbott obviously has been the biggest contributor to the day. Uh,

16
00:00:54,400 --> 00:00:56,320
Speaker 1: it was a good time for Abbott to come in

17
00:00:56,360 --> 00:00:59,160
Speaker 1: for this acquisition St Jude. I've been covering healthcare for

18
00:00:59,200 --> 00:01:02,920
Speaker 1: thirteen fourteen years. St Jude has been a perennial target

19
00:01:03,440 --> 00:01:06,120
Speaker 1: every single year to the point where you think you

20
00:01:06,160 --> 00:01:08,520
Speaker 1: know what this company is never going to be acquired,

21
00:01:08,800 --> 00:01:12,120
Speaker 1: so they get acquired. The valuation if you if you

22
00:01:12,160 --> 00:01:14,560
Speaker 1: look at where they're trading at right now, around seventy

23
00:01:14,600 --> 00:01:17,560
Speaker 1: nine per share, the valuation is in line to what

24
00:01:17,640 --> 00:01:21,520
Speaker 1: it was in July last year. So it would probably

25
00:01:21,600 --> 00:01:25,000
Speaker 1: seem that the deals are happening because the valuations are

26
00:01:25,160 --> 00:01:29,560
Speaker 1: down in healthcare and that's biotech, medical devices, life science tools,

27
00:01:29,600 --> 00:01:32,640
Speaker 1: all those companies. So we're starting to see executives think,

28
00:01:32,920 --> 00:01:35,120
Speaker 1: you know what, I don't think we're going to get

29
00:01:35,120 --> 00:01:37,920
Speaker 1: back to the July level. So this valuation is the

30
00:01:37,959 --> 00:01:42,000
Speaker 1: new norm. So billion today, it could have been thirty

31
00:01:42,200 --> 00:01:44,840
Speaker 1: to thirty five billion last year in a deal. And

32
00:01:44,959 --> 00:01:47,760
Speaker 1: the share price is down a little bit today, yes,

33
00:01:48,280 --> 00:01:51,480
Speaker 1: so if you think about the acquisition, the shares are

34
00:01:51,520 --> 00:01:53,560
Speaker 1: If you think about Abbott, the shares are down about

35
00:01:53,600 --> 00:01:57,000
Speaker 1: eight point eight percent, and there's been some scrutiny around

36
00:01:57,400 --> 00:01:59,960
Speaker 1: uh the deal in terms of St. Jude's sluggish grow

37
00:02:00,160 --> 00:02:03,760
Speaker 1: So it's been sluggish and in recent revenue growth performance,

38
00:02:03,760 --> 00:02:06,880
Speaker 1: they've been concerns about the path to top line re acceleration.

39
00:02:07,360 --> 00:02:10,160
Speaker 1: And then obviously Abbott getting in on Cardiac where the

40
00:02:10,240 --> 00:02:14,480
Speaker 1: management that's been pretty flat so that's kind of putting

41
00:02:14,480 --> 00:02:16,600
Speaker 1: a few people off. They're still going to do the

42
00:02:16,600 --> 00:02:20,000
Speaker 1: A Layer deal. It's it seems so, I mean, they've

43
00:02:20,040 --> 00:02:23,280
Speaker 1: reassured that five I mean, as I said, billion dollars

44
00:02:23,360 --> 00:02:24,760
Speaker 1: used to be a lot of money. I guess five

45
00:02:24,840 --> 00:02:28,720
Speaker 1: point eight billion doesn't count for all they can do exactly.

46
00:02:29,160 --> 00:02:31,600
Speaker 1: They they've said they're committed to the deal, even though

47
00:02:31,919 --> 00:02:35,119
Speaker 1: obviously the DJ is still poking around there. Obviously going

48
00:02:35,160 --> 00:02:39,520
Speaker 1: back to the sales how how A Layer conducted itself

49
00:02:39,600 --> 00:02:42,680
Speaker 1: on the sales front. So there they seem very much

50
00:02:42,720 --> 00:02:47,120
Speaker 1: committed to that. So way in on Santa fees a

51
00:02:47,160 --> 00:02:51,079
Speaker 1: big deal and uh more more billions of dollars offered

52
00:02:51,080 --> 00:02:55,440
Speaker 1: on the table. This is an interesting situation because Metivation

53
00:02:55,600 --> 00:02:58,800
Speaker 1: is partnered with Estellus on Astandi, which is their top

54
00:02:58,800 --> 00:03:03,239
Speaker 1: selling drug, their top selling prodect cancer drug. And people

55
00:03:03,240 --> 00:03:05,840
Speaker 1: are thinking, well, hey, you know, there's a clause that

56
00:03:05,919 --> 00:03:10,520
Speaker 1: says if if there's an unsolicited bid on Metivation, then

57
00:03:10,840 --> 00:03:14,720
Speaker 1: then a Stellist stand still goes away. So does a

58
00:03:14,800 --> 00:03:17,200
Speaker 1: Stellis come in It would make sense for their pipeline.

59
00:03:17,240 --> 00:03:20,120
Speaker 1: People are also asking, come on, you know, this bid

60
00:03:20,240 --> 00:03:24,160
Speaker 1: is seen as quite low relative to what metivations valuation

61
00:03:24,160 --> 00:03:26,600
Speaker 1: should be. So there may be other people, other parties

62
00:03:26,639 --> 00:03:29,000
Speaker 1: interested here, So no, if you no doubt, may go

63
00:03:29,200 --> 00:03:32,800
Speaker 1: up into the sixty range on their potential offer, but

64
00:03:32,840 --> 00:03:35,640
Speaker 1: they started at a range that they had probably put

65
00:03:35,640 --> 00:03:38,640
Speaker 1: down about two weeks ago when they approached metivation. Now

66
00:03:38,680 --> 00:03:41,680
Speaker 1: they just made this public um, this offer public today.

67
00:03:42,080 --> 00:03:44,480
Speaker 1: Sasha Domoni, thank you so very much. Our first word

68
00:03:44,480 --> 00:03:47,040
Speaker 1: healthcare reporter here at Bloomberg News